The widespread and steady use of new drugs in oncology has resulted in the need to optimize their interaction and synergy with stereotactic radiation therapies. In modern radiotherapy, the use of advanced technology provides better local control of many cancers, reducing the side effects and duration of treatments. Simultaneously, systemic therapies improved control over the spread of diseases and quality of life of patients with locally advanced or metastatic tumors. These new instruments at our disposal in our fight against cancer raise questions of the relevance of some high volume radiation treatments and their doses. The Symposium will involve national and international speakers and moderators.
The event is free and accredited on Agenas for the provision of 11 CME credits (for italian participants).
THE SYMPOSIUM IS OPEN TO
100 health care professionals with the following roles and specializations:
HOW TO REGISTER
This REGISTRATION FORM must be fully completed, signed, and e-mailed before November 15 to: firstname.lastname@example.org
The Organizing Secretariat will email you a registration confirmation. As CME credits will be granted to the first 100 registered professionals, we recommend a prompt registration.
For further information:
Organizing Secretary and CME Provider
Via Michele Mercati 33 – 00197, Rome
T +39 06 80693320 – email@example.com
Directions to UPMC San Pietro FBF.
The UPMC San Pietro FBF Advanced Radiotherapy Center offers innovative radiotherapy treatments and stereotactic radiosurgery with advanced protocols of care for patients with oncology diseases.
The Italian division of the University of Pittsburgh Medical Center with facilities in Rome (UPMC San Pietro FBF, oncology radiotherapy and UPMC | Salvator Mundi International Hospital UPMC), Palermo (ISMETT IRCCS, organ transplants and highly specialized therapies and Ri.MED Foundation, research), Chianciano Terme (UPMC Institute for Health, preventive medicine and Medical Gym), Mirabella Eclano (UPMC Hillman Cancer Center at Villa Maria, oncology radiotherapy).
UPMC is an integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, U.S.A. With its high clinical, management, research and training skills, UPMC is one of the leading health systems in the United States. UPMC Hillman Cancer Center UPMC's oncology network offering the latest advances in cancer prevention, detection, diagnosis, and treatment.